Solar urticaria caused by visible light in a 33-year-old male refractory to treatment with omalizumab
Recommended Citation
Wright E, Kurland E, and Lim HW. Solar urticaria caused by visible light in a 33-year-old male refractory to treatment with omalizumab. Photodermatol Photoimmunol Photomed 2020.
Document Type
Article
Publication Date
3-5-2020
Publication Title
Photodermatology, photoimmunology & photomedicine
Abstract
Solar urticaria (SU) is a rare photodermatosis characterized by development of urticarial papules and plaques within minutes of exposure to ultraviolet (UV)A, UVB, or visible light. It is an immunoglobulin (Ig)E‐mediated photodermatosis likely caused by a photo allergen activated by a particular light spectrum. Solar urticaria has significant impact on patient's quality of life and often poses a therapeutic challenge. We present the case of solar urticaria induced by visible light in a 33‐year‐old man that presented as an erythematous, urticarial plaque after 15‐minute exposure to fluorescent light while receiving omalizumab therapy.
PubMed ID
32141097
ePublication
ePub ahead of print
